FDA Inspection 1298668 — Maxxos-Medical Gmbh
The FDA completed an inspection of Maxxos-Medical Gmbh on December 17, 2025 in Mahlstetten. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 17, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Mahlstetten (Germany)